MALT1 in cerebrospinal fluid: a prognostic biomarker and potential therapeutic target in Alzheimer’s disease

This study demonstrates a causal association between CSF metabolites and AD risk, highlighting MALT1 as a promising biomarker and potential therapeutic target for AD.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2026-01-06
DOI
https://doi.org/10.3389/fneur.2025.1732729
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MALT1 in cerebrospinal fluid: a prognostic biomarker and potential therapeutic target in Alzheimer’s disease

Jia Tian, ChuanZheng Sun, Ping Qi, Siyi Jiang et al.
Frontiers in Neurology
Alzheimer's disease research and treatments
article

MALT1 in cerebrospinal fluid: a prognostic biomarker and potential therapeutic target in Alzheimer’s disease

Jia Tian, ChuanZheng Sun, Ping Qi, Siyi Jiang, huaizheng liu
article en

Abstract

This study demonstrates a causal association between CSF metabolites and AD risk, highlighting MALT1 as a promising biomarker and potential therapeutic target for AD.

Frontiers in NeurologyVol. 16
Rocky Vista University (US), Central South University (CN), Zunyi Medical University (CN), Third Xiangya Hospital (CN)
Openalex Percentile: Top 96%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.